A potential CAR T-cell therapy by Innovative Cellular Therapeutics (ICT) showed early signs of safety and efficacy, significantly reducing tumor size in four patients with thyroid or colorectal cancer, new data show. These findings will be shared in two presentations this Friday, May 15, at the ongoing 23rd American Society of Gene & Cell Therapy Annual Meeting, held online this year because of COVID-19. The presentations are titled “CoupledCARTM Technology for Treating Thyroid Cancer” (page 554)…
May 13, 2020May 13, 2020